Octagon Capital Advisors as of March 31, 2025
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 34 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 9.3 | $48M | 27M | 1.76 | |
| Apellis Pharmaceuticals | 8.9 | $46M | 2.1M | 21.87 | |
| Dianthus Therapeutics (DNTH) | 8.2 | $43M | 2.3M | 18.14 | |
| Arrivent Biopharma (AVBP) | 7.4 | $38M | 2.1M | 18.49 | |
| Centessa Pharmaceuticals Sponsored Ads Put Option | 5.6 | $29M | 2.0M | 14.38 | |
| Trevi Therapeutics (TRVI) | 4.0 | $21M | 3.3M | 6.29 | |
| Gossamer Bio (GOSS) | 3.9 | $20M | 18M | 1.10 | |
| Ocular Therapeutix (OCUL) | 3.4 | $18M | 2.4M | 7.33 | |
| Mind Medicine Mindmed Com New (MNMD) | 3.4 | $18M | 3.0M | 5.85 | |
| Cogent Biosciences (COGT) | 3.2 | $17M | 2.8M | 5.99 | |
| Kalvista Pharmaceuticals | 3.1 | $16M | 1.4M | 11.54 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.9 | $15M | 11M | 1.39 | |
| Nuvation Bio Com Cl A (NUVB) | 2.7 | $14M | 7.9M | 1.76 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.7 | $14M | 217k | 63.49 | |
| Tourmaline Bio (TRML) | 2.7 | $14M | 905k | 15.21 | |
| Merus N V (MRUS) | 2.5 | $13M | 308k | 42.09 | |
| Pharvaris N V (PHVS) | 2.3 | $12M | 770k | 15.70 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.2 | $12M | 296k | 39.07 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $11M | 904k | 12.29 | |
| Atyr Pharma Com New (ATYR) | 2.1 | $11M | 3.6M | 3.02 | |
| Scholar Rock Hldg Corp (SRRK) | 2.0 | $11M | 329k | 32.15 | |
| Verastem Com New (VSTM) | 2.0 | $10M | 1.7M | 6.03 | |
| Regulus Therapeutics | 1.6 | $8.1M | 4.6M | 1.75 | |
| Silverback Therapeutics (SPRY) | 1.5 | $7.9M | 625k | 12.58 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.5 | $7.7M | 1.2M | 6.25 | |
| Erasca (ERAS) | 1.4 | $7.0M | 5.1M | 1.37 | |
| Miragen Therapeutics (VRDN) | 1.2 | $6.1M | 450k | 13.48 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.1 | $5.9M | 1.1M | 5.31 | |
| Unicycive Therapeutics | 1.1 | $5.7M | 10M | 0.57 | |
| Maze Therapeatics (MAZE) | 1.0 | $5.2M | 468k | 11.01 | |
| Perspective Therapeutics Com New (CATX) | 0.9 | $4.8M | 2.3M | 2.13 | |
| Kalaris Therapeutics (KLRS) | 0.7 | $3.9M | 481k | 8.03 | |
| Neurogene (NGNE) | 0.7 | $3.5M | 303k | 11.71 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.5 | $2.8M | 250k | 11.30 |
